share

T Lymphocyte Early-Activation Protein CAS NO 156320-25-1


Unit Price:

CAS No.:156320-25-1

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

T Lymphocyte Early-Activation Protein CAS NO 156320-25-1 is a high-purity biochemical reagent critical for immunological research and therapeutic development. This protein plays a fundamental role in the study of T-cell activation pathways, immune response modulation, and related disease mechanisms. It is an essential tool for researchers and developers in the fields of immunology, oncology, and autoimmune disease research, where precise and reliable biological activity is paramount.

Application

  • Immunological Research: A key reagent for studying T-cell receptor signaling, early activation events, and immune synapse formation in vitro.
  • Drug Discovery & Development: Used in high-throughput screening (HTS) assays to identify and validate novel immunomodulators, checkpoint inhibitors, and therapeutic antibodies.
  • Biomarker Studies: Employed in the development of diagnostic assays to detect and quantify T-cell activation states in clinical samples.
  • Cell-Based Therapy R&D: Essential for optimizing the activation and expansion protocols of T-cells in CAR-T and other adoptive cell therapy manufacturing processes.
  • Vaccine Adjuvant Research: Investigated for its potential to enhance specific immune responses as part of novel vaccine formulations.
  • Autoimmune & Inflammatory Disease Models: Used to elucidate pathological mechanisms and test potential interventions in relevant experimental models.

Basic Information

Product Name T Lymphocyte Early-Activation Protein
CAS No. 156320-25-1
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms Early T-Lymphocyte Activation Protein; T-Cell Early Activation Protein; T-Cell Activation Antigen; CD69 (Cluster of Differentiation 69); AIM (Activation Inducer Molecule); EA 1; MLR-3; Leu-23; BL-Ac/p26; Early Activation Antigen CD69
EINECS Contact for details

Quality Control

Our T Lymphocyte Early-Activation Protein is produced under stringent quality management systems. Each batch undergoes comprehensive analytical testing, including purity analysis by HPLC, biological activity assays, and endotoxin level testing, to ensure consistency and performance for critical research applications. Certificates of Analysis (COA) detailing purity, concentration, and specific activity are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below in aliquots to avoid repeated freeze-thaw cycles. This product is hygroscopic (moisture-sensitive); ensure the container is sealed tightly after each use. Handle using aseptic techniques appropriate for labile proteins.

Specification

Item Specification
Appearance White to off-white lyophilized powder
Identification (SDS-PAGE) Corresponds to standard
Purity (HPLC) ≥ 95%
Protein Content (BCA) ≥ 90%
Biological Activity (Cell-based assay) Confirmed
Endotoxin Level (LAL) < 1.0 EU/μg
Solubility Soluble in PBS or appropriate aqueous buffer

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.